Advertisement

Topics

Latest "Standard & Poor’s" News Stories - Page: 4

21:36 EST 21st January 2018 | BioPortfolio

Here are the most relevant search results for "Standard & Poor’s" found in our extensive news archives from over 250 global news sources.

More Information about Standard & Poor’s on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Standard & Poor’s for you to read. Along with our medical data and news we also list Standard & Poor’s Clinical Trials, which are updated daily. BioPortfolio also has a large database of Standard & Poor’s Companies for you to search.

Showing "Standard Poor" News Articles 76–100 of 3,300+

Tuesday 16th January 2018

Gyros Protein Technologies Introduces Multi-Species Kit for Toxicokinetic Studies

Gyrolab Generic TK Kit for early-stage biotherapeutic development, optimized for use in Gyrolab systems Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today it has introduced a new reagent kit for early-stage biotherapeutic toxicokinetic (TK) studie...


Intermountain Healthcare Partners with Newport Credentialing Solutions to Provide Cloud-Based Provider Enrollment Software and Services

Newport Helps Hospitals and Health Systems Improve Efficiencies and Revenue Newport Credentialing Solutions, the industry’s leading provider of cloud-based credentialing and provider enrollment software and services, today announced that it has partnered with Intermountain

Saniona AB: Saniona initiates Phase I study with new Tesomet tablet

PRESS RELEASE January 16, 2018 Saniona, a leading biotech company in the field of ion channels, today announced that it has dosed the first 10 participants in a Phase 1 pharmacokinetic study of Tesomet using the new patented single tablet formulation. The trial will comprise a total of 60 volunteers. Saniona expects to report results from the trial in the second quarter 2018. "...


project44 Announces Multimodal Integration into MercuryGate TMS

New solution seamlessly automates LTL, Volume LTL and Full Truckload activities directly within current MercuryGate workflows CHICAGO (PRWEB) January 16, 2018 Today, project44 launches an expanded integration into MercuryGate TMS that brings full-lifecycle automation and unprecedented end-to-end visibility to Full Truckload and Volume LTL shipments. This latest solution joins project44’s existi...

Anthem Blue Cross and Blue Shield in Kentucky Offers Medicare Supplement Plans with Innovative Benefits to Help Members Control Healthcare Costs

Consumers in Kentucky with Original Medicare will be able to enroll in a Medicare Supplement Innovative Plan F or Innovative Select F from Anthem Blue Cross and Blue Shield in Kentucky (Anthem), with coverage starting February 1, 2018. Anthem's Innovative Plan F and Innovative Select F provide hearing and vision benefits as well as 24/7 nursing support via ...

Tenax Therapeutics Announces Plan to Develop Levosimendan for a Pulmonary Hypertension Indication with No FDA Approved Therapies

Phase 2 Trial will investigate Levosimendan in Pulmonary Hypertension-WHO Group 2 patients with preserved ejection fraction (PH-HFpEF) Tenax Therapeutics, Inc. (NASDAQ: TENX) today announced plans to advance the development of levosimendan for the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction ...

Periodontist Justin M. Cifuni, DMD; MSD Adds LANAP Laser Procedure to Treatment Services

Boston area gum disease patients can make an appointment to see Dr. Cifuni for a less invasive, less painful treatment than traditional surgery. BOSTON (PRWEB) January 16, 2018 Boston area Periodontist Dr. Justin M. Cifuni now offers the LANAP® protocol to treat patients with gum disease and LAPIP™ protocol for ailing dental implants. As a LANAP-trained clinician, Dr. Cifuni is at the fore...

Ni-Q Presents HDM PLUS®, Safety Tested Human-Donated Breast Milk for At-Risk Infants

Ni-Q, an Oregon-based company, announced today the successful introduction and reception of HDM Plus, its human-donated milk for at-risk infants. HDM Plus is a unique, commercially sterile, non-fortified, calorically enhanced, safety tested human donor milk for premature and low-birth-weight infants in Neonatal Units, Labor and Delivery units, and other hospital environments. WILSONVILLE, Ore. (PR...

SWIR Camera for Radiometry & Temperature Calibrated Applications

FLIR Systems A6260sc camera sets the standard for Short Wavelength Infrared (SWIR) cameras for science and R&D applications by combining high-speed performance with fully customizable features. Incorporating a proprietary high-resolution detector, the A6250sc camera offers improved sensitivity and linearity across the full dynamic range, making it ideal for radiometry and temperatur...

SYGNIS AG Installs Scalable Production Capability for Lightning-Link Antibody Conjugation Technology

Lightning-Link is now available in volumes from 10µg to 100mg Direct-labeling technology provides excellent batch-to-batch consistency and high performance Bulk supply of ultra-high quality Lightning-Link raw materials also now available Heidelberg, Germany and Cambridge, UK, 16 January 2018 – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), the Grou...

Context Therapeutics Announces the Acquisition of Apristor™ (Onapristone XR), an Investigational Phase 2 Drug for Metastatic Breast Cancer

Apristor has demonstrated efficacy in 120 patients in two Phase 2 Trials Context will initiate multiple clinical trials evaluating Apristor as a monotherapy or a combination therapy over the next 18 months Metastatic Breast Cancer market is approaching $4B despite unmet patient needs Context Th...

Man ruptures his throat by holding nose and closing mouth during a sneeze – Evening Standard

Evening StandardMan ruptures his throat by holding nose and closing mouth during a sneezeEvening StandardDoctors have warned against closing your mouth when you sneeze after a man ruptured his throat. A 34-year-old man, who was previously fit and well, spent a week in hospital barely able to speak and swallow after suffering the injury, a report in the ...Don't hold in a sneeze, warn doctors. It c...

TEKLYNX and AIS Announce January 25th Live Webinar: Barcode Verification for UDI and Global Medical Device Labeling

Free Webinar Provides Barcode Verification Education for Medical Device Labeling MILWAUKEE (PRWEB) January 16, 2018 TEKLYNX International, the world’s leading barcode and RFID labeling software developer and solutions provider, and leading barcode verification provider Automatic Identification Systems (AIS) today announced it will co-present a live free webinar titled Barcode Verification for U...

Monday 15th January 2018

20152023 World Hearing Diagnostic Devices Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 12122017] Prices from USD $2800

SummaryHearing Diagnostic Devices is a machine used for hear testing and evaluating hearing loss .They usually consist of an embedded hardware unit connected to a pair of headphones and a test subject feedback button, sometimes controlled by a standard PC.This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end indust...

Mar-a-Lago, President Trump's 'Winter White House,' Has Been Cited for Poor Maintenance

Health inspectors found 15 violations in the club's two main kitchens

The gold standard of scientific evidence

That is the title of my latest article in Pharmaceutical Market Europe. An excerpt is below. Randomised controlled trials (RCTs) are regarded as the gold standard of scientific evidence, and for good reason. By randomizsing a treatment across study arms, RCTs eliminate patient-treamtent selection bias, resulting in reliable causal inference. In contrast, in the real […]

[Comment] The long road towards a safe and effective treatment of chronic Chagas disease

Chagas disease, a chronic systemic parasitosis by the kinetoplastid protozoon Trypanosoma cruzi, is the leading cause of cardiac morbidity and mortality in poor rural and suburban areas of Latin America and the source of the largest parasitic disease burden in the American continent. This burden is now spreading worldwide owing to international migration.1,2 A recent change in the scientific under...

[Articles] Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial

E1224 is the first new chemical entity developed for Chagas disease in decades. E1224 displayed a transient, suppressive effect on parasite clearance, whereas benznidazole showed early and sustained efficacy until 12 months of follow-up. Despite PCR limitations, our results support increased diagnosis and access to benznidazole standard regimen, and provide a development roadmap for novel benznida...

Mental health service utilization is associated with retention in care among persons living with HIV at a university-affiliated HIV clinic

Mental health (MH) comorbidities reduce retention in care for persons living with HIV (PLWH) and are associated with poor health outcomes. Optimizing retention in primary care is vital, as poor retention is as...

Test for Personalized Approach to Hodgkin's Lymphoma Treatment Entering Final Stages Before Commercialization

Source: Streetwise Reports   01/16/2018 One analyst believes 2018 could mark a 'dramatic turnaround' for this biotech company, which is at the forefront of using three-dimensional telomere analysis to personalize medical treatment. 3D Signatures Inc. (DXD:TSX.V; TDSGF:OTCQB; 3D0:FSE) has developed a propriety software platform, TeloView, that conducts 3D analysis of ch...

BioVie Reviews Key Accomplishments in 2017 and Updates on Phase 2a Clinical Trial Progress

BEVERLY, MA--(Marketwired - January 16, 2018) - BioVie Inc. (OTCQB: BIVI), a clinical-stage company focused on the development and commercialization of innovative drug therapies for liver disease, today reviewed key milestones achieved over the past year and provided a general update on the progress of its mid-stage (Phase 2a) clinical trial of BIV201 in refractory ascites patients. "We made exce...

Portable Laser-Operated Counterfeit Drug Identifier (CoDI) for Tablets

Counterfeit drugs (also known as “fake or falsified medicines”) have become a major world-wide public health concern. Falsified medicines may contain toxic substances, the wrong active ingredients, suboptimal amounts of active ingredients, or no active ingredients at all. CDC researchers developed a portable (handheld), battery-operated, and relatively inexpensive device that non-trained perso...

Broadcast regulations aren’t enough to protect kids from TV junk food ads

Science blog It seems obvious that advertising unhealthy food and drink leads to people eating and drinking more of it. UK businesses wouldn’t have spent an estimated £21 billion on ads in 2016 if they didn’t work. But it’s difficult to know exactly who TV advertising is working on, and whether it’s leading those people to do things they otherwise wouldn’t. We are particularly worrie...

3D Doppler ultrasound can better determine fetal growth restriction than 2D ultrasound

3D doppler ultrasound can better determine fetal growth restriction than 2D version


Quick Search
Advertisement

 

News Quicklinks